LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,625,744 | +70.4% | 262,405 | +22.4% | 0.01% | +60.0% |
| Q2 2023 | $10,341,164 | 0.0% | 214,458 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $10,341,164 | +13.5% | 214,458 | +17.5% | 0.01% | 0.0% |
| Q4 2022 | $9,110,251 | -100.0% | 182,497 | -63.1% | 0.01% | -54.5% |
| Q3 2022 | $20,190,941,000 | -24.3% | 494,876 | +2.0% | 0.01% | -21.4% |
| Q2 2022 | $26,682,645,000 | +344.6% | 485,139 | +193.8% | 0.01% | +366.7% |
| Q1 2022 | $6,000,897,000 | +7.0% | 165,132 | +37.2% | 0.00% | +50.0% |
| Q4 2021 | $5,608,768,000 | +427.1% | 120,334 | +381.3% | 0.00% | +100.0% |
| Q2 2020 | $1,064,000,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $54,715,742 | 20.16% |
| HHLR ADVISORS, LTD. | 6,436,533 | $432,341,922 | 9.65% |
| Paradigm Biocapital Advisors LP | 2,025,480 | $136,051,492 | 9.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,828 | $75,487,527 | 9.13% |
| RA Capital Management | 6,264,707 | $420,800,369 | 8.28% |
| Iron Triangle Partners LP | 452,629 | $30,403,090 | 4.44% |
| Nicholas Investment Partners, LP | 593,010 | $39,832,482 | 2.98% |
| Old Well Partners, LLC | 45,200 | $3,036,084 | 2.63% |
| Avidity Partners Management LP | 967,000 | $64,953,390 | 2.62% |
| E Fund Management (Hong Kong) Co., Ltd. | 52,759 | $3,544 | 2.23% |